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To identify a drug that is safe, affordable and effective 
is a challenge to modern medicine today. Current 
estimates are that it may cost as much as over a 
billion  dollar  to develop a drug  by  a  pharmaceutical 
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company.[1] Drug discovery strategies based on 
natural products and traditional medicine are re-
emerging as attractive options.[2] A folk medicine or 
Ayurvedic drug which has already been in use for 
many years having anecdotal evidence of efficacy for 
the treatment of a disease (which is also presumed to 
be safe) can be tested for efficacy in a clinical trial. 
This method has been described as 'reverse 
pharmacology’.[3] The drugs commonly used to treat 
inflammation and arthritis include glucocorticoids like 
cortisone and prednisone, NSAIDS like Ibuprofen and 
naproxen etc., disease-modifying anti-inflammatory 
and anti-rheumatic drugs like Methotrexate (MTX) 
and leflunomide etc., and newer therapies such as 
biological response modifiers like tumor necrosis 
factor, alpha blocking agents, anti-CD 20 therapy 
(rituximab) and abatacept which are often required to 
inhibit or halt the underlying immune processes. 
A B S T R A C T  
Background: Leonotis nepetifolia (L.)R.Br. (LN) belonging to Lamiaceae family is a tall erect annual 
weed native to Southern India and tropical Africa used by tribals and folklore traditions in India for 
cough, fever, stomach ache, skin ailments, kidney diseases, rheumatism and dysmenorrhoea. The 
purpose of the study was to evaluate the anti-arthritic activity of the traditional dosage form( 
decoction) as used by the tribals in comparison to a modified dosage form(dry aqueous extract ) of 
whole plant of LN in experimental animal models. Materials and Methods: Thirty wistar strain albino 
rats were selected and randomly divided into five groups. Arthritis was induced by Freund’s complete 
adjuvant (FCA) and then treated with either the decoction of whole plant of LN or the dry aqueous 
extract for 30 days.The various parameters like paw volume, ponderal changes, serum biochemical 
parameters and histopathological changes were assessed. The data was analyzed by employing one-
way ANOVA followed by Dunnet’s multiple‘t’ test for unpaired data to determine significant difference 
between groups at P<0.05. Results: In the present study it was observed that dry aqueous extract 
form of the test drug is having weak activity against primary oedema whereas decoction form did not 
show any effect on primary oedema. Both forms of test drug have comparable values as standard 
drug on 25th day in secondary oedema. Conclusion: The findings suggest the beneficial effect of the 
drug against chronic inflammation and inhibition of periarthritis and osteogenic activity.  
Key words: Leonotis nepetifolia, Granthiparni, Anti-arthritic activity, ethnomedical, chronic  
        inflammation. 
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However, besides high costs, all of these drugs are 
associated with numerous side effects, severe adverse 
reactions and toxicity, including some risk of 
infections in subsets of patients who are being treated 
with biological response modifiers.[4],[5] Leonotis 
nepetifolia (L.)R.Br. belonging to Lamiaceae family, 
native to Southern India and tropical Africa is used by 
tribals and folklore traditions in India. LN roots are 
considered as the source plant for Granthiparni 
according to The Ayurvedic Pharmacopoeia of India, 
Part 1, Volume 3. At least, 23 ethnomedical claims are 
available on its use in various ailments from different 
parts of India.[6] One such claims reported from 
Andhra Pradesh is on its use in joint complaints. The 
decoction made of 20 g of whole plant of LN(Seerinta- 
local name) in 50 ml of water and given once a day is 
known to relieve patients with joint pain.[7] Few 
extracts of the plant have been explored for its 
analgesic, anti-inflammatory and anti-arthritic 
potential. The most noted studies are by Hortensia 
Parra-Delgado et al, (2004) on several extracts of 
aerial parts of LN showing anti-inflammatory activity 
on TPA-induced edema model in mice. Leonotinine 
was identified as the active constituent with marked 
anti inflammatory activity.[8] Manocha N et al, (2012) 
reported the anti-inflammatory and anti-rheumatic 
activities of methanolic extract of capitulum(flowering 
head) of LN.[9] Stigmasterol and Leonotinin[10] isolated 
from the plant has shown significant anti-
inflammatory activity. Flavonoids present in the plant 
are also said to attribute anti-inflammatory effect. 
An analysis of the tribal claims and previous 
pharmacological works indicates the potential of the 
plant to be an anti arthritic drug which needs to be 
validated through preclinical, safety and efficacy trials. 
Hence the present pharmacological study was 
designed to evaluate the efficacy of thedecoction 
(traditional dosage form) and dry aqueous extract 
(modified dosage form) of  LN in suitable animal 
experimental models for its anti-arthritic activity. 
MATERIALS AND METHODS 
Animals 
Wistar strain albino rats of either sex weighing 
between 170 to 250 g were used for the 
experiments.The selected animals were kept under 
acclimatization for 7 days before dosing. The 
experimental protocols were approved by 
Institutional Animal Ethics Committee 
(Ph.D./IAEC/10/2012/07) in accordance with the 
guidelines formulated by CPCSEA, India. 
Plant material 
Collection of Plant material 
The whole plant of LN was collected during its 
flowering season in the month of November from 
Mankarai region, Coimbatore, Tamil Nadu.It was 
authenticated (No.BSI/SRC/5/23/12-13 Tech/1757) at 
the Botanical Survey of India, Southern Regional 
Centre, Coimbatore and a voucher specimen (No. 
IPGT&RA/6066/12-13) was deposited at the 
Pharmacognosy Lab, Institute for Post Graduate 
Teaching & Research in Ayurveda, Gujarat Ayurved 
University, Jamnagar for future reference. 
Preparation of Dosage form 
For pharmacological evaluation, coarse powder of the 
test drug was used to prepare decoction as per 
classical method. One part of drug to 16 parts of 
water and reduced to quarter part. Aqueous extract 
of the whole plant was prepared with the total yield 
of 16.4%. Decoction was administered without 
diluting it, while for extract; stock solution of suitable 
concentration was prepared freshly with distilled 
water just prior to administration.   
Dose Fixation 
Dose of the drug was calculated by extrapolating the 
human therapeutic dose to rat on the basis of body 
surface area ratio (conversion factor 0.018 for rat) by 
referring to the table of Pagets and Barnes (1964).[11] 
Human dose of LN decoction is 50 ml per day as used 
by the tribals, hence the dose for rat was calculated as 
4.5 ml/kg body weight of rat. Similarly the human 
dose of extract was fixed as 1000 mg/day based on 
which the dose for rat was decided as 90 mg/kg body 
weight of rat. 
Route of administration 
The test drugs suspension administered according to 
the body weight of the animals by oral route with the 
help of oral feeding canula. 
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Chemicals 
Freund’s complete adjuvant (FCA) was purchased 
from Sigma Aldrich (Product no. F5881). 
Dexamethasone IP (Batch No. LM 1399) obtained 
from Cadila Healthcare Limited, Ahmedabad. All 
chemicals or reagents used in the experimental study 
were procured from standard and reputed firms and 
were generally and whenever available are of 
analytical grade regularly used in the laboratory. 
Evaluation of test drug effect on Freund’s complete 
adjuvant induced arthritis in rats 
The selected animals were grouped into five groups of 
6 rats each. First group (normal control) was 
administered tap water. Second group (arthritic 
control) was administered  tap water orally and 
injected with FCA. Third group (Dry aqueous extract) 
was administered with 90mg/kg body weight dry 
aqueous extract of  LN orally (p.o.).  Fourth group 
(Decoction) was treated with 4.5ml/kg body weight 
decoction of LN p.o. The fifth group (reference 
standard [RS]) was administered with the standard 
drug Dexamethasone (100 μg/kg). The test drugs and 
RS were administered for 30 consecutive days. On day 
1, the complete FCA was made into fine emulsion with 
the help of a syringe and 0.1 ml of it was injected 
beneath the plantar aponeurosis in the left hind paw 
and 0.05 ml subcutaneously into the root of the tail. 
The volumes of both the hind paws were measured 
with the help of digital plethysmometer just before 
the adjuvant injection (initial). Paw volumes of both 
hind limbs were recorded on the day of adjuvant 
injection and again measured on 2nd, 5th, 10th, and 
15th day, and 15th, 20th, 25th, and 30th day for 
primary and secondary oedema respectively. Paw 
volume of the 0 (initial) days were taken as the 
reference value for determining the increase in paw 
volume on the subsequent days. The animals were 
observed daily for the appearance of secondary 
lesion. On 30thday after one hour of drug 
administration, animals were weighed again and 
anaesthetized by anaesthetic ether and blood was 
collected from retro orbital plexus by capillary 
puncturing and used for estimation of serum 
biochemical parameters. Parameters such as blood 
urea,[12] serum creatinine,[13] serum glutamate 
oxaloacetate transaminase,[14] serum glutamate 
pyruvate transaminase,[15] and serum alkaline 
phosphatase[16] were estimated by feeding requisite 
quantity of serum to the auto analyzer (Fully 
Automated Biochemical Random Access Analyzer, 
BS‑200; Lilac Medicare Pvt. Ltd., Mumbai, 
Maharashtra, India) which was automatically drawn in 
to the instrument for estimating different parameters. 
References given in the kit literature mentioning the 
basis of the methods on which test procedures was 
carried out.[17] Further both right and leftsynovial 
joints were dissected out and the histopathological 
slides were prepared by referring to standard 
procedure. The slides were viewed under trinocular 
research Carl‑Zeiss’s microscope at various 
magnifications to note down the changes in the 
microscopic features.  
Statistical Analysis 
The data generated during the study were analyzed by 
employing Student ‘t’ test and one-way ANOVA 
followed by Dunnet’s multiple ‘t’ test for unpaired 
data to determine significant difference between 
groups at P<0.05. 
RESULTS 
FCA induced rat paw oedema 
The values at different time intervals were compared 
with initial paw volume of respective group and the 
percentage increase in paw volume was calculated. 
Suppression in primary paw (left paw) volume was not 
observed in either of the test drug groups on 2nd and 
5th day compared to the arthritic control group. 
Insignificant decrease was observed in primary 
oedema in both test drug administered groups carried 
out on 10th and 15thday in comparison to arthritic 
control group. A significant suppression in primary 
oedema was observed in dexamethasone treated 
groups on 10th (p<0.05) and 15thday (p<0.01) of 
arthritis induction in comparison to arthritic control 
group. (Table 1) 
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Table 1: Effect of test drugs on Primary paw oedema 
(oedema of left hind paw) 
Groups Percentage increase in paw edema 
compared to initial paw volume 










































Data: Mean ± SEM; *P<0.05, **P<0.01(comparison to 
arthritic control group, unpaired t-test) SEM= Standard 
error of the mean 
Freund’s adjuvant induced arthritis produced increase 
in secondary odema (i.e. right paw oedema) after 12th 
day in all rats. Arthritic control group showed 
maximum secondary oedma on 20th day.  Marked 
suppression of secondary paw oedema was observed 
on 20th and 25th day in both extract treated and 
decoction treated groups in comparison to arthritic 
control group. However only extract treated group 
showed statistically significant (p<0.05) result in 
suppression of secondary oedema in comparison to 
arthritic control group. Reference standard group 
showed significant decrease in secondary paw 
oedemaon 20th and 25thday in comparison to control 
group. (Table 2) 
Table 2: Effect of test drugs on Secondary paw 
oedema (oedema of right hind paw) 
Groups Percentage increase in paw 
















































Data: Mean ± SEM; *P<0.05, **P<0.01(comparison to 
arthritic control group, unpaired t-test) SEM= Standard 
error of the mean 
Ponderal changes 
Table 3 illustrates the effect of test drugs on body 
weight of Freund’s adjuvant induced arthritic rats. 
Normal control rats showed progressive increase in 
body weight of rats. Arthritic control rats showed 
significant decrease (25.20%) in body weight in 
comparison to initial values. Test and standard drugs 
also showed decrease in body weight but magnitude 
was less as compared to arthritic control group. (Table 
3) 
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Biochemical estimation 
Out of all the biochemical parameters studied, 
significant increase was found in blood urea and non-
significant increase in alkaline phosphatase level in 
Freund’s arthritic control group in comparison to the 
normal control group. Serum creatinine was found 
decreased significantly in the decoction group in 
comparison to the arthritic control. All other 
parameters were found unaffected in drug and 
standard drugs treated groups in comparison to the 
control group and arthritic control group. (Table 4) 



































































































In Freund’s adjuvant arthritis control rat remarkable 
degenerative changes in the form of bone and 
cartilage erosion and synovial membrane proliferation 
were observed in both the joints. These changes were 
found to be very much decreased in both the dosage 
of test drug and reference standard administered 
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The Freund’s adjuvant induced arthritis model in rats 
is frequently used to evaluate anti‑arthritic activity of 
new drugs as it closely resembles clinical arthritis.[18] 
Therefore, this model is used with a relatively high 
degree of validity for evaluating agents with potential 
anti‑arthritic activity. Four phases of arthritis are 
established by researchers on the basis of biochemical 
markers of arthritis viz., days 1– 4 with acute local 
inflammation and systemic effects, days 7–12 with 
remission of acute inflammation and periarthritis, 
days 12-28 with chronic inflammation, periarthritis, 
and osteogenic activity and day 35 onward with 
permanent articular deformity and minimal 
inflammation.[19] This model has been used to study 
subchronic or chronic inflammation in rats and is of 
considerable relevance  to understand  
patho‑physiology and pharmacological control of 
inflammatory processes. 
The determination of paw swelling is considered a 
simple, sensitive, and quick procedure for evaluating 
the degree of inflammation and assessing the 
therapeutic effects of drugs. In this study, rats were 
selected as an animal model sincethey develop a 
chronic swelling in multiple joints with an influence of 
inflammatory cells and followed by erosion of 
cartilage in joints and destruction of bones. Paw 
volumes of both hind limbs were recorded on the day 
of adjuvant injection and again measured on 2nd, 5th, 
10th, and 15th day, and 15th, 20th, 25th and 30th day 
for primary and secondary oedema respectively. The 
15th day measurement is indicative of primary lesions 
and then onward measurement aids in estimating 
secondary lesions. On 21st day, the secondary phase 
of rheumatoid arthritis becomes more evident and 
inflammatory changes spread systemically and 
become observable in the limb not injected with 
Freund’s adjuvant. This is because of the 
manifestation of cell mediated immunity.[20] 
In the present study it was observed that LN extract 
form is having weak activity against primary oedema 
whereas  LN decoction form did not show any effect 
on primary oedema. RS group showed significant 
decrease in primary oedema in rats on 10th and 15th 
day compared to FA control group. This indicates 
presence of weak anti-inflammatory activity in LN 
extract form and significant anti-inflammatory activity 
in reference standard. 
The symptoms of secondary lesion, such as swelling of 
the non-injected hind foot, of the ears, of the nose, 
and on the tail were observed at the 12th day, after 
injection of Freund’s adjuvant. The test drug in both 
the dosage forms showed effect on secondary 
oedema. Dry aqueous extract treated group showed 
significant decrease in secondary paw oedema on 20th 
day and 25th day. Decoction form of LN also showed 
the similar values and inhibitory effect as shown by 
extract form in secondary oedema. Both forms of test 
drug have comparable values as standard drug on 25th 
day in secondary oedema. In dexamethasone treated 
group significant suppression of secondary oedema 
was observed on 20th and 25th day compared to FA 
control group. Since secondary oedema represents 
cell mediated immunity it is possible that there is an 
immunomodulatory component in the observed anti-
arthritic activity in test formulations. The findings 
suggest the beneficial effect of the drug against 
chronic inflammation and inhibition of periarthritis 
and osteogenic activity.  
This observation was further evidenced by 
histopathological study where joints from both 
dosage forms of LN and RS treated animals showed 
remarkable protection against Freund’s adjuvant 
induced degenerative changes in the form of cartilage 
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erosion, synovial membrane proliferation and 
hyperplasia in both the joints. 
































































Among the serum biochemical parameters studied 
only one parameter was affected to significant extent 
by injection of Freund’s adjuvant. Statistically 
significant increase in blood urea was observed in 
arthritic control group in comparison to normal 
control group. Increased blood urea level was 
reported in arthritic rats and it was hypothesized that 
substantial fraction of blood urea in arthritic rats 
comes from arginine synthesized in the kidney.[21] The 
test formulations and RS did not have any significant 
influence on this parameter. 
Body weight is considered as an indirect index of 
health status and recovery from disease. A change in 
body weight of rats is measured as one of the 
parameter to assess the course of the disease and the 
response to therapy of anti-inflammatory and 
anti‑arthritic drugs. As the incidence and severity of 
arthritis is increased, a decrease in body weights of 
the rats occurs during the course of the experimental 
period and this observation is by the findings of 
previous study on alterations in the metabolic 
activities of diseased rats.[22] It has been suggested 
that, the decrease in body weight during 
inflammation is due to deficient absorption of 
nutrients through the intestine and that treatment 
with anti-inflammatory drugs normalizes the process 
of absorption.[23] In the present study, none of the 
groups showed weight gain except the normal control 
group. Arthritic control group showed marked 
decrease in body weight in comparison to initial 
values. Weight loss in the test drugs and standard 
groups were found to be lower in comparison to 
arthritic control group. 
CONCLUSION 
The overall assessment of pharmacological data 
revealed that folklore claim on the use of whole plant 
of L. nepetifolia in joint complaint is valid. 
Pharmacological studies suggest the beneficial effect 
of both dosage forms of L. nepetifolia against chronic 
inflammation and inhibition of periarthritis and 
osteogenic activity.  
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